Hi Scott (I'm taking a wild guess that's your name) Please forgive me if its not,
I hope you are well Champion. The play with ATH434 for MSA has always been to license it out or to sell it. One way or another, the plan was never to take it to Phase 3. As Pivalde eluded to earlier, if the results are good enough, having Orphan Status means we get to potentially get a pass on the Phase 3 Study. We still have some hurdles we need to overcome before we can even get into discussions around licensing etc. Their is a small possibility the "Open Label Trials" due in July won't be as spectacular as the "Double Blinded Placebo Study" due in November of this year. The reason I say that is, the 12 patients enrolled in the open label are long term sufferers of MSA. MSA is fully entrenched in their brain. Treating it may take longer than a year to see real definitive results where as, the Double Blinded Placebo Study has over 60 Patients currently enrolled and they are all relatively new sufferers of MSA.
The results will soon speak for themselves. At the end of the day, as long as we get the desired result by years end, that's all that matters. The biggest advantage of being fully funded until the "Double Blinded Placebo Study" results are due is, nothing will hinder our progress until then. It would be a massive shot in the arm if we can show undeniable physical improvement for long term sufferers, in such a short amount of time of receiving treatment. That would almost certainly guarantee huge results at the end of the year.
Its definitely interesting times with this little Company. I am sure we have some Pharmaceutical Companies watching from the sidelines with a keen eye on how we progress. In the next few months we shall start to see a steady flow of news come through.
On a totally different note, Its great to see People back here at the ATH Thread. For a while there it was like an old abandoned building. It was very rare to see any human life here. The only other person here was
@pivalde. He was like the site security guard. There literally was no one else here. I am hoping the results from our studies will help rebuild our brand and create Company awareness. I am sure if the SP starts its migration north it will pique peoples interest to come and take a look at what it is we are selling. It will be great to have the hoards of people back here. Its always nice listening to other peoples opinions and potentially learning a thing or two.
Wishing all Shareholders are terrific weekend!
GLTAHs
Stockman
(20min delay)